Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
‘I love this work, but it’s killing me’: The unique toll of being a spiritual leader today - 2Exploring Being a parent: A Survey of \Bits of knowledge and Guidance for Guardians\ Nurturing Book
- 3Which Carrier Do You Suggest? Vote
- 4Grasping the Commencement of Criminal Cases: An Extensive Outline
- 5Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
- Undeniably popular Historical centers: Where Craftsmanship and History Meet
- I'm 18 and founded an AI startup. I have to wake up at 3 a.m. to work on it before school, but it's worth every sleepless night.
- Scientists solve the mystery of 'impossible' merger of 'forbidden' black holes
- 6 Famous Urban communities for Shopping on the planet
- 6 Modest and Strong Tire Brands
- Netflix’s Price Hikes Just Got Rejected by an Italian Court. Here’s Why It Matters Everywhere
- Artemis 2 moon rocket gets 'America 250' paint job | Space photo of the day for Dec. 23, 2025
- World’s tallest bridge and biggest museum named ‘greatest places of 2026’
- ‘Trip of suffering’: Gaza evacuee details 24-hour journey to South Africa
